About Biolog-id
Biolog-id is a company based in Bernay (France) founded in 2005 by Jean-Claude Mongrenier.. Biolog-id has raised $33.22 million across 3 funding rounds from investors including Xerys and Altamira Capital Partners. The company has 6 employees as of April 07, 2024. Biolog-id offers products and services including Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution. Biolog-id operates in a competitive market with competitors including Beijing Hongcheng Innovation Technology, InVita Healthcare Technologies, HemaTerra, Motryx and Vericell, among others.
- Headquarter Bernay, France
- Employees 6 as on 07 Apr, 2024
- Founders Jean-Claude Mongrenier
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biolog - Id India Private Limited
- Date of Incorporation 13 May, 2021
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$278.57 K (USD)0as on Mar 31, 2023
-
Net Profit
$-188.42 K (USD)-139.25as on Mar 31, 2023
-
EBITDA
$-96.35 K (USD)-62.86as on Mar 31, 2023
-
Total Equity Funding
$33.22 M (USD)
in 3 rounds
-
Latest Funding Round
$33.22 M (USD), Series B
Nov 20, 2019
-
Investors
Xerys
& 1 more
-
Employee Count
6
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biolog-id
Biolog-id offers a comprehensive portfolio of products and services, including Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manages blood products from donation to transfusion for better chain control.
Ensures full traceability of plasma for medicinal product compounding.
Optimizes workflow for secure injectable therapies administration.
Unlock access to complete
Funding Insights of Biolog-id
Biolog-id has successfully raised a total of $33.22M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $33.22 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $33.2M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Series B - Biolog-id | Valuation | Xerys |
|
| Nov, 2016 | Amount | Series A - Biolog-id | Valuation | Xerys |
|
| Mar, 2011 | Amount | Series A - Biolog-id | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biolog-id
Biolog-id has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Xerys and Altamira Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Xerys is engaged in private equity investment management.
|
Founded Year | Domain | Location | |
|
European private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biolog-id
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biolog-id
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biolog-Id Comparisons
Competitors of Biolog-id
Biolog-id operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Hongcheng Innovation Technology, InVita Healthcare Technologies, HemaTerra, Motryx and Vericell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
IoT chips for biological sample tracking are developed.
|
|
| domain | founded_year | HQ Location |
Specialized software solutions are provided for regulated healthcare industries.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive inventory management solutions tailored for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Blood-specimen transport conditions are monitored via hardware and software.
|
|
| domain | founded_year | HQ Location |
Traceability solutions for blood samples are offered by Vericell.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biolog-Id
Frequently Asked Questions about Biolog-id
When was Biolog-id founded?
Biolog-id was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Where is Biolog-id located?
Biolog-id is headquartered in Bernay, France. It is registered at Bernay, Eure, France.
Who is the current CEO of Biolog-id?
Bruno Chappert is the current CEO of Biolog-id.
Is Biolog-id a funded company?
Biolog-id is a funded company, having raised a total of $33.22M across 3 funding rounds to date.
How many employees does Biolog-id have?
As of Apr 07, 2024, the latest employee count at Biolog-id is 6.
What is the annual revenue of Biolog-id?
Annual revenue of Biolog-id is $278.57K as on Mar 31, 2023.
What does Biolog-id do?
Biolog-id was founded in 2005 in Bernay, France, where traceability solutions for health products are developed. Operations focus on the biotech sector, targeting labile blood products such as packed red blood cells, platelets, and therapeutic plasma, as well as plasma for fractionation and chemotherapy injectables. Services ensure product monitoring and compliance across the supply chain in the healthcare industry.
Who are the top competitors of Biolog-id?
Biolog-id's top competitors include Beijing Hongcheng Innovation Technology, InVita Healthcare Technologies and Motryx.
What products or services does Biolog-id offer?
Biolog-id offers Biolog Transfusion Solution, Biolog Plasma Solution, and Biolog Oncology Solution.
Who are Biolog-id's investors?
Biolog-id has 2 investors. Key investors include Xerys, and Altamira Capital Partners.